Patents by Inventor Yong Gong

Yong Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200399254
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Inventors: Jie Chen, Matthew Donahue, Heng-Keang Lim, Ronghui Lin, Rhys Salter, Jiejun Wu, Yong Gong
  • Publication number: 20200373778
    Abstract: Provided in the embodiments of the present disclosure are a charging method, apparatus and system, a charging circuit, a terminal and a charging system. The method includes: detecting a working parameter of a to-be-charged terminal during charging, wherein the working parameter reflects a state of the to-be-charged terminal during charging (S202); and adjusting a working state of a charging conversion circuit in the to-be-charged terminal according to the working parameter, wherein different working states correspond to different charging efficiencies (S204).
    Type: Application
    Filed: November 19, 2018
    Publication date: November 26, 2020
    Inventor: Yong GONG
  • Patent number: 10800764
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Grant
    Filed: August 13, 2018
    Date of Patent: October 13, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jie Chen, Matthew Donahue, Heng-Keang Lim, Ronghui Lin, Rhys Salter, Jiejun Wu, Yong Gong
  • Patent number: 10712353
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: July 14, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong
  • Publication number: 20200053416
    Abstract: Systems and methods are described herein for a media guidance application that can cause a specific portion of a media asset to be stored based on a user command. For example, if the user requests the closing scene from a given movie, the media guidance application may detect the command, determine that it comprises an instruction to store a portion of a media asset, identify a source of the portion of the media asset, and cause the portion of the media asset to be stored. The media guidance application may also cause the entirety of the media asset to be stored and initiate playback at the start of the requested portion. This may allow users to store and watch portions of particular interest without requiring that the users seek through the entire media asset on their own.
    Type: Application
    Filed: July 22, 2019
    Publication date: February 13, 2020
    Inventors: Paul Maltar, Milan Patel, Yong Gong
  • Publication number: 20200040107
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: September 30, 2019
    Publication date: February 6, 2020
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Eric HRYHORENKO, Banumathi SANKARAN, Thomas R. DeCORY, Theresa TUBBS, Linda COLT, Bart M. REMMERIE, Rhys SALTER, Matthew Garrett DONAHUE, Yong GONG
  • Publication number: 20200002438
    Abstract: Disclosed is an antibody or a binding fragment thereof which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody or the fragment thereof can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: September 17, 2019
    Publication date: January 2, 2020
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10465013
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: November 5, 2019
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong
  • Publication number: 20190315885
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 17, 2019
    Applicant: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10435478
    Abstract: Disclosed is an antibody or a binding fragment thereof which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody or the fragment thereof can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: October 8, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10425680
    Abstract: Systems and methods are described herein for a media guidance application that can cause a specific portion of a media asset to be stored based on a user command. For example, if the user requests the closing scene from a given movie, the media guidance application may detect the command, determine that it comprises an instruction to store a portion of a media asset, identify a source of the portion of the media asset, and cause the portion of the media asset to be stored. The media guidance application may also cause the entirety of the media asset to be stored and initiate playback at the start of the requested portion. This may allow users to store and watch portions of particular interest without requiring that the users seek through the entire media asset on their own.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: September 24, 2019
    Assignee: Rovi Guides, Inc.
    Inventors: Paul Maltar, Milan Patel, Yong Gong
  • Publication number: 20190271712
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: May 13, 2019
    Publication date: September 5, 2019
    Applicant: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10344098
    Abstract: Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of olanzapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: July 9, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10288631
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: May 14, 2019
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew G. Donahue, Yong Gong
  • Patent number: 10284943
    Abstract: Provided are a method and apparatus for adjusting a sound field of an earphone, a terminal, and an earphone. The method includes acquiring a loudness data difference between first and second earplugs of an earphone connected to a terminal; determining a current sound field parameter of the earphone according to the loudness data difference; judging whether the current sound field parameter is substantially the same as a pre-set sound field parameter by comparison; and when the current sound field parameter is not the same as the pre-set sound field parameter, adjusting gain parameters of first and second channels of the terminal according to the current sound field parameter and the pre-set sound field parameter, so that the current sound field parameter of the earphone reaches the pre-set sound field parameter.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: May 7, 2019
    Assignee: ZTE CORPORATION
    Inventor: Yong Gong
  • Publication number: 20180346454
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Application
    Filed: August 13, 2018
    Publication date: December 6, 2018
    Inventors: Jie CHEN, Matthew DONAHUE, Heng-Keang LIM, Ronghui LIN, Rhys SALTER, Jiejun WU, Yong GONG
  • Patent number: 10071991
    Abstract: The present invention is directed to substituted pyridine derivatives, pharmaceutical compositions containing said derivatives and the use of said derivatives in the treatment of disorders mediated by c-fms kinase. The present invention is further directed to a process for the preparation of said substituted pyridine derivatives.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: September 11, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jie Chen, Matthew Donahue, Heng-Keang Lim, Ronghui Lin, Rhys Salter, Jiejun Wu, Yong Gong
  • Publication number: 20180213317
    Abstract: Provided are a method and apparatus for adjusting a sound field of an earphone, a terminal, and an earphone. The method includes acquiring a loudness data difference between first and second earplugs of an earphone connected to a terminal; determining a current sound field parameter of the earphone according to the loudness data difference; judging whether the current sound field parameter is substantially the same as a pre-set sound field parameter by comparison; and when the current sound field parameter is not the same as the pre-set sound field parameter, adjusting gain parameters of first and second channels of the terminal according to the current sound field parameter and the pre-set sound field parameter, so that the current sound field parameter of the earphone reaches the pre-set sound field parameter.
    Type: Application
    Filed: September 23, 2015
    Publication date: July 26, 2018
    Inventor: Yong GONG
  • Patent number: 10021497
    Abstract: A method, apparatus and a computer storage medium for selecting a microphone are disclosed. The method includes: employing ultrasonic measurement to determine a microphone, which is closest to a primary sound source, of a matrix of a plurality of microphones arranged in a device for recording sound; and taking the microphone which is closest to the primary sound source as the current primary microphone and taking other microphones of the matrix of the plurality of microphones as secondary microphones, wherein the primary microphone is used to collect the primary sound source, and the secondary microphones are used to collect ambient noise.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: July 10, 2018
    Assignee: ZTE Corporation
    Inventor: Yong Gong
  • Publication number: 20180105606
    Abstract: Disclosed is an antibody which binds to quetiapine, which can be used to detect quetiapine in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of quetiapine, including multiplex detection of aripiprazole, olanzapine, quetiapine, and risperidone in a single lateral flow assay device.
    Type: Application
    Filed: December 18, 2017
    Publication date: April 19, 2018
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Eric Hryhorenko, Banumathi Sankaran, Thomas R. DeCory, Theresa Tubbs, Linda Colt, Bart M. Remmerie, Rhys Salter, Matthew Garrett Donahue, Yong Gong